Identification of Subtypes of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome DataSriganesh Jammula, Vijayendran Sujendran, Matthew Eldridge et al.|Gastroenterology|2020Cited by 110
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinomaFergus Noble, Jamie Kelly, Megan Lloyd et al.|British journal of surgery|2017Cited by 108
Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent CohortsTarek Sawas, Richard J.E. Skipworth, Sarah Killcoyne et al.|Gastroenterology|2018Cited by 91
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinomaThanos P. Mourikis, Shaun R. Preston, Lorena Benedetti et al.|Nature Communications|2019Cited by 49
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1Edwin Garcia, Annette Hayden, Charles N. Birts et al.|Scientific Reports|2016Cited by 24